HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arnd Kleyer Selected Research

Janus Kinases

12/2021[Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].
12/2020JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arnd Kleyer Research Topics

Disease

23Rheumatoid Arthritis
02/2024 - 01/2014
12Inflammation (Inflammations)
02/2024 - 09/2016
11Arthritis (Polyarthritis)
02/2024 - 10/2016
10Psoriatic Arthritis
10/2023 - 01/2018
7COVID-19
12/2023 - 01/2020
5Synovitis
02/2024 - 01/2018
5Infections
12/2023 - 01/2021
5Autoimmune Diseases (Autoimmune Disease)
08/2023 - 01/2017
5Osteoarthritis
01/2022 - 03/2015
4Psoriasis (Pustulosis Palmaris et Plantaris)
10/2023 - 11/2018
3Pain (Aches)
01/2022 - 01/2019
3Rheumatic Diseases (Rheumatism)
01/2022 - 01/2020
3Gout
10/2020 - 01/2015
2Osteophyte
01/2022 - 10/2020
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
03/2021 - 01/2021
2Postmenopausal Osteoporosis
05/2013 - 12/2012
1Osteitis
02/2024
1Arthralgia (Joint Pain)
02/2024
1Tenosynovitis
02/2024
1Simian Acquired Immunodeficiency Syndrome
12/2023
1Antisynthetase syndrome
07/2023
1Body Weight (Weight, Body)
10/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022
1Muscular Diseases (Myopathy)
10/2022
1Breakthrough Infections
09/2022
1Post-Acute COVID-19 Syndrome
01/2022
1Connective Tissue Diseases (Connective Tissue Disease)
01/2022
1Hypersensitivity (Allergy)
01/2022
1Periostitis
01/2022
1Pulmonary Tuberculosis
01/2022
1Virus Diseases (Viral Diseases)
12/2021
1Hypoxia (Hypoxemia)
11/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Asthma (Bronchial Asthma)
01/2021
1Insulin Resistance
01/2021
1Musculoskeletal Diseases (Musculoskeletal Disease)
01/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2014
10AntibodiesIBA
07/2023 - 01/2014
9Antirheumatic Agents (DMARD)IBA
05/2023 - 01/2016
9AutoantibodiesIBA
10/2022 - 09/2016
6Immunoglobulin G (IgG)IBA
08/2023 - 01/2017
5baricitinibIBA
11/2023 - 12/2020
4Anti-Citrullinated Protein AntibodiesIBA
02/2024 - 01/2016
3MicroRNAs (MicroRNA)IBA
10/2023 - 03/2015
3VaccinesIBA
08/2023 - 01/2022
3Janus Kinase InhibitorsIBA
12/2021 - 12/2020
3RNA (Ribonucleic Acid)IBA
12/2021 - 01/2019
3Uric Acid (Urate)IBA
10/2020 - 01/2015
3Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2018
2Abatacept (Orencia)FDA Link
02/2024 - 01/2021
2Immunoglobulin A (IgA)IBA
01/2023 - 01/2020
2Methotrexate (Mexate)FDA LinkGeneric
11/2022 - 01/2019
24-hexyloxyaniline (HOA)IBA
01/2022 - 01/2020
2Immunoglobulin M (IgM)IBA
01/2022 - 12/2021
2Janus KinasesIBA
12/2021 - 12/2020
2Rituximab (Mabthera)FDA Link
03/2021 - 01/2021
2tofacitinibIBA
01/2021 - 12/2020
2CytokinesIBA
12/2020 - 01/2020
2secukinumabIBA
01/2020 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 05/2013
23-benzoyl dopamine (MBDA)IBA
01/2019 - 09/2016
1Immunomodulating AgentsIBA
05/2024
1acetyl 4-aminosalicylic acidIBA
02/2024
1Interleukin-1 (Interleukin 1)IBA
12/2023
1Neutralizing AntibodiesIBA
12/2023
1Circulating MicroRNAIBA
10/2023
1Monoclonal AntibodiesIBA
08/2023
1tixagevimabIBA
08/2023
1cilgavimabIBA
08/2023
1CollagenIBA
01/2023
1LipidsIBA
01/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022
1Chimeric Antigen ReceptorsIBA
10/2022
1fludarabineIBA
10/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022
1DNA (Deoxyribonucleic Acid)IBA
10/2022
1Voriconazole (Vfend)FDA LinkGeneric
01/2022
1C-Reactive ProteinIBA
01/2022
1EnzymesIBA
01/2022
1Tumor Necrosis Factor InhibitorsIBA
01/2022
1ImmunosorbentsIBA
01/2022
1InterferonsIBA
01/2022
1N 30IBA
01/2022
1ametantrone (HAQ)IBA
01/2022
1Nucleocapsid ProteinsIBA
01/2022
1casirivimab and imdevimab drug combinationIBA
01/2022
1Myeloblastin (Proteinase 3)IBA
01/2022
1upadacitinibIBA
01/2022
1Complement System Proteins (Complement)IBA
11/2021
1InflammasomesIBA
11/2021
1TOR Serine-Threonine KinasesIBA
11/2021
1Infliximab (Remicade)FDA Link
03/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1mepolizumabIBA
01/2021
1dehydroacetic acid (DHAS)IBA
01/2021
1Small Cytoplasmic RNAIBA
01/2021

Therapy/Procedure

11Therapeutics
02/2024 - 01/2016
2Ovariectomy (Oophorectomy)
12/2020 - 12/2012
1Precision Medicine
10/2023
1Lasers (Laser)
01/2023